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Abstract 
 
We report a 23-year-old man and three members of his family with Hb J-Iran confirmed by electrophoresis, chain 
separation by high performance liquid chromatography and sequencing. Alpha thalassemia was also confirmed 
in two family members. The substitution at β77 led to a higher negative charge of the βJ-Iran subunit, which 
enhanced its electrostatic attraction for the normal positively-charged α subunit. Therefore, more Hb J-Iran than 
Hb A forms in the red blood cells of heterozygotes. In α-thalassemia, the more attractive βJ-Iran subunit out-
competes βA subunits in forming assemblies with deficient α subunits, so even more Hb J-Iran was formed. 
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Introduction 
 
Hb J-Iran (β77 His→Asp) is one of the hemoglobin 
variants that initially have been discovered in Iran. The 
substitution at β77 leads to a higher negative charge on 
the surface of the βJ-Iran subunit, which enhances its 
electrostatic attraction for the normal positively, 
charged α subunit. As a result, red cells in heterozy-
gous individuals contain more Hb J-Iran than Hb A. 
 
 
Case report 
 
A 23-year-old man with mild jaundice and anemia 
was referred to the Hematology Research Center and 
Genetic and Prenatal Diagnosis of Thalassemia and 
Hemophilia Service of Datgheib and Nemazee Hospi-
tal (the main reference hospitals affiliated to Shiraz 
University of Medical Sciences in Shiraz, southern 
Iran) for premarital screening for thalassemia. On 
physical examination, he was asymptomatic and had 
no clinical manifestations. However, hemoglobin 
electrophoresis at pH 8.6 (Helena, Process-24, Beau-
mont, TX, USA) detected a band located between 
Hb A1 and Hb H (Figure 1). The proportion of this un-
known band was determined by capillary electrophore-
sis (Sebia, Capillarys 2, and Norcross, GA, USA). 
 
 
Fig. 1: Hb electrophoresis of the proband (Patient no. 
3) at pH: 8.6 detected a band located between Hb A1 
and Hb H. 
 
To determine the nature of the unknown Hb, chain 
separation by high performance liquid chromatog-
raphy (HPLC) was used. The lysate was injected in a 
Vydac column in a Waters system (Waters, Breeze, 
Milford, MA, USA), and comparison of the retention 
times identified the unknown band as a β variant 
(Figure 2). The β gene was sequenced with an ABI 310 
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Genetic Analyzer (Applied Biosystems, Carlsbad, 
CA, USA) to detect the mutation or deletion which 
caused the formation of this hemoglobin. By compar-
ing sequencing graphs for normal and sample se-
quences, we detected a mutation in codon 77 (CAC 
>GAC) which caused the β77 His→Asp substitution 
in the β chain (Hb J-Iran) (Figure 3). Molecular stud-
ies of the alpha globin gene found the homozygous 
form of the 3.7-kbp deletion (-α
-3.7/-α
-3.7), the probable 
cause of mild hypochromic microcytic anemia in the 
proband (diagnosed by blood smear prepared from 
fresh blood and stained with Wright stain). 
To detect long deletions in the alpha gene, gap-
PCR was done, and to detect mutations or deletions, 
the reverse dot blot method was used according to the 
manufacturer’s protocol for the strip assay α globin 
gene kit (Viennalab, Vienna, Austria). Further studies 
were done in five of the proband’s siblings and his 
mother (his father had died before he was referred to 
our center). The results are summarized in Table 1. 
 
 
Discussion 
 
Because there are two genes for β-globin, an individ-
ual heterozygous for a β globin variant would be ex-
pected to have equal proportions of normal and ab-
normal hemoglobins. However, some β variants are 
synthesized significantly less than normal β globin, so 
the level of these variants (such as E, Lepore, Knos-
sos, K-Woolwich and Vicksburg) would be below 
that of normal Hb A-a situation associated with the 
thalassemic phenotype. In heterozygous individuals 
with forms of unstable hemoglobins such as Koln and 
 
Fig. 2: Chain separation in the proband by HPLC. The β chain retention time was shorter than the α chain time, and 
because the total proportion of the βA and variants was almost equal to the proportion of total α chain, we conclud-
ed that the variant was a β variant. Dehghani et al. 
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Zurich, the proportion of Hb variants is also below 
that of normal hemoglobin. Differences between the 
levels of normal and other variant hemoglobins re-
flect the different tendencies of variants assemble 
with normal alpha subunits.
1 
In heterozygous forms of hemoglobinopathies 
with the β variant chain, the normal β chain has a 
greater affinity to combine with the α chain and form 
Hb A1 compared with the abnormal β chain, so the 
amount of Hb  A1 is usually greater than abnormal 
hemoglobin. This situation is more obvious in indi-
viduals with both α-thalassemia and a heterozygous 
form of hemoglobinopathy, because the normal β 
chain has a stronger tendency to assemble with the 
deficient α chain present in α-thalassemia and is thus 
more successful in forming Hb A1 than in individuals 
with only heterozygous forms of hemoglobinopathies. 
The J-Iran variant (β77 His→Asp), first reported 
in Iran,
2 was subsequently found in Turkey
3 and in a 
Russian-Armenian family.
4 The substitution at β77 
leads to a higher negative charge on the surface of the 
βJ-Iran subunit, which enhances its electrostatic at-
traction for the normal positively charged α subunit. 
As a result, red cells in heterozygous individuals con-
tain more Hb J-Iran than Hb A. In the presence of α-
thalassemia, the more attractive βJ-Iran subunit will 
be even more successful in combining with the defi-
cient  α subunits, so that even more Hb  J-Iran is 
formed (unlike the situation with other β variants 
such as Hb S and Hb C). The same mechanism is re-
sponsible for the greater proportion of Hb J-Baltimore 
than Hb A. Competition experiments with the βA and 
βJ-Baltimore subunits in vitro showed that when α 
subunits are deficient, Hb  J formation would be 
greater than in individuals without α-thalassemia.
1,5 
In 1987, Rahbar et al. described a 14-year-old Per-
sian girl who had 65% Hb J-Iran, but who also had 
Hb  H disease with three α gene deletions, which 
probably explains the difference in the amount of 
Hb J-Iran between this girl and the family reported 
here. Her two siblings had 50% Hb J-Iran and proba-
bly silent or minor α-thalassemia.
1 In Turkey, the first 
    
Fig. 3: β gene sequence in the proband (B) compared to a normal sequence (A). A mutation was detected in codon 77 
(CAC >GAC), which caused the β77 His→Asp substitution in the β chain (Hb J- Iran). The arrows show codon 77. 
 
 
Table 1: Hematological results in the proband and family members
a
  Mild hemo-
chromic 
microcytic 
anemia 
Hb 
(g/dL) 
Hct 
(%) 
MCV 
(fL) 
MCH 
(pg) 
MCHC 
(g/dL) 
RBC 
count 
(10
6/µL) 
Pres-
ence of 
J-Iran 
Hb 
Amou
nt of 
J-Iran 
Hb 
Geno-
type of 
α-globin 
chain  
Proband  Yes  13.2  43.0 72.0 22.1 30.7  5.97  Yes  52.2  -α
-3.7/-α
-3.7 
Mother  No  12.2  41.8 87.1 25.4 29.2  4.80  Yes  54.3  -α
-3.7/αα 
1st sister  No  13.4  44.4  86.2 26.0 30.2 5.15 Yes 49.8  αα/αα
2nd  sister No  13.8  44.9 90.7 27.9 30.7  4.95  Yes  49.5  αα/αα 
3rd  sister  No  13.4  43.3 86.9 26.9 30.9  4.98  No  ND
a  αα/αα 
1st brother  Yes  13.1  46.3  72.0 20.4 28.3 6.43 No ND  -α
-3.7/-α
-3.7
2nd  brother  No  15.8  48.0 80.0 26.3 32.0  6.00  No  ND  -α
-3.7/αα 
a ND=Not detected α-thalassemia and hemoglobin J-Iran 
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person with Hb J-Iran (β77 His → Asp) was reported 
in 1986 by Arcasoy et al.
3 Since then, five cases have 
been reported in the Turkish population, from Anka-
ra, Antalya and Mugla.
6 
The proband, his mother and siblings did not need 
blood transfusions and were advised to take 5 mg fo-
lic acid daily. They had no apparent health problems 
related to the hemoglobin variant, and we assume that 
Hb J-Iran functions correctly in their bodies. To in-
vestigate Hb  J-Iran functioning, O2  saturation and 
erythropoietin (EPO) levels are useful because when 
O2 saturation is normal, EPO secretion and thus serum 
EPO levels are normal. However, when O2 saturation 
is below normal (as in some hemoglobin disorders), 
the increased EPO secretion stimulates red blood cell 
production to compensate for this defect. When the 
compensatory mechanism operates, no anemia or ap-
parent health problems are apparent aside from an 
increase in serum EPO levels.  
 
 
Acknowledgements 
 
We thank Shirin Parand of the Hematology Research 
Center, Nemazee Hospital, and Shiraz for editorial 
assistance and K. Shashok (AuthorAID in the Eastern 
Mediterranean) for improving the use of English in 
the manuscript. 
 
Conflict of interest: None declared. 
 
 
References 
 
 
 
 
1  Rahbar  S, Bunn HF. Association 
of  hemoglobin  H  disease with 
Hb J-Iran (beta 77 His----Asp): im-
pact on subunit assembly. Blood 
1987;70:1790-1. [3676514] 
2  Rahbar  S, Beale D, Isaacs WA, 
Lehmann  H.  Abnormal  haemo-
globins in Iran. Observation of a 
new variant-- haemoglobin J Iran 
(alpha-2-beta-2 77 His--Asp). Br 
Med  J  1967;1:674-7. [6019668] 
[http://dx.doi.org/10.1136/bmj.1.5
541.674] 
3  Arcasoy  A, Turhanoglu I, Goz-
dasoglu S, Ogur G. First observa-
tion of hemoglobin J-Iran [beta 77 
(EF1)His----Asp] in Turkey.  Hemo-
globin. 1986;10:209-13. [3957698] 
[http://dx.doi.org/10.3109/03630268
609046446] 
4  Delanoe-Garin J, Rhoda MD, 
Craescu CT, Bardakjian J, Blou-
quit Y, Lacombe C, Arous N, 
Poyart C, Ganeval D, Girot R, et 
al. Hemoglobin J Iran alpha 2 be-
ta 2 77  (EF1) his----Asp in a Rus-
sian-Armenian family.  Hemoglo
bin 1986;10:365-78. [2943700] [http: 
//dx.doi.org/10.3109/036302686089
96868] 
5  Mrabet NT, McDonald MJ, Turci S, 
Sarkar R, Szabo A, Bunn HF. Elec-
trostatic attraction governs the 
dimer  assembly  of  human he-
moglobin.  J  Biol  Chem 1986;261: 
5222-8. [3957922] 
6  Akar N, Akar E, Özdemir S. A fur-
ther case of Hb J-Iran [beta77 (EF1) 
His Asp] in Mu la,  Turkey.  Turk  J 
Hematol 2007;24:37-8. 
 